References
- Achour B, Barber J, Rostami-Hodjegan A. (2011). Cytochrome P450 pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry. Drug Metab Dispos 39:2130–4
- Adachi K, Suemizu H, Murayama N, et al. (2015). Human biofluid concentrations of mono(2-ethylhexyl)phthalate extrapolated from pharmacokinetics in chimeric mice with humanized liver administered with di(2-ethylhexyl)phthalate and physiologically based pharmacokinetic modeling. Environ Toxicol Pharmacol 39:1067–73
- Berry LM, Li C, Zhao Z. (2011). Species differences in distribution and prediction of human V(ss) from preclinical data. Drug Metab Dispos 39:2103–16
- Hosseinpour F, Wikvall K. (2000). Porcine microsomal vitamin D(3) 25-hydroxylase (CYP2D25). Catalytic properties, tissue distribution, and comparison with human CYP2D6. J Biol Chem 275:34650–5
- Koyanagi T, Nakanishi Y, Murayama N, et al. (2015). Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole, and metoprolol in cynomolgus monkeys using in vitro–in vivo correlation. Xenobiotica 45:312–21
- Koyanagi T, Yamaura K, Yano K, et al. (2014). Age-related pharmacokinetic changes of acetaminophen, antipyrine, diazepam, diphenhydramine, and ofloxacin in male cynomolgus monkeys and beagle dogs. Xenobiotica 44:893–901
- Miyaguchi T, Suemizu H, Shimizu M, et al. (2015). Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling. Regul Toxicol Pharmacol 72:71–6
- Mogi M, Toda A, Iwasaki K, et al. (2012). Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to microminipigs. J Toxicol Sci 37:1157–64
- Rendic S, Guengerich FP. (2012). Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol 25:1316–83
- Sakai C, Iwano S, Yamazaki Y, et al. (2014). Species differences in the pharmacokinetic parameters of cytochrome P450 probe substrates between experimental animals, such as mice, rats, dogs, monkeys, and microminipigs, and humans. J Drug Metab Toxicol 5:173
- Shida S, Utoh M, Murayama N, et al. (2015). Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling. Xenobiotica 45:881–6
- Takano R, Murayama N, Horiuchi K, et al. (2010). Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling. Regul Toxicol Pharmacol 58:252–8
- Turpault S, Brian W, Van HR, et al. (2009). Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol 68:928–95
- Yamazaki H. (2014). Species, ethnic, and individual differences in human drug-metabolizing cytochrome P450 enzymes. In: Yamazaki H, ed. Fifty years of cytochrome P450 research. Tokyo: Springer, 293–305